Form 8-K - Current report:
SEC Accession No. 0001140361-22-037955
Filing Date
2022-10-20
Accepted
2022-10-20 16:01:58
Documents
17
Period of Report
2022-10-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ny20005570x4_8k.htm   iXBRL 8-K 36849
2 EXHIBIT 1.1 ny20005570x4_ex1-1.htm EX-1.1 153036
3 EXHIBIT 5.1 ny20005570x4_ex5-1.htm EX-5.1 15110
4 EXHIBIT 99.1 ny20005570x4_ex99-1.htm EX-99.1 29667
8 ny20005570x4_ex5-1img01.jpg GRAPHIC 8451
9 ny20005570x4_ex99-1img01.jpg GRAPHIC 70265
  Complete submission text file 0001140361-22-037955.txt   535027

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA insm-20221019.xsd EX-101.SCH 3860
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE insm-20221019_lab.xml EX-101.LAB 22547
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE insm-20221019_pre.xml EX-101.PRE 16041
11 EXTRACTED XBRL INSTANCE DOCUMENT ny20005570x4_8k_htm.xml XML 4065
Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807
Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900
INSMED Inc (Filer) CIK: 0001104506 (see all company filings)

EIN.: 541972729 | State of Incorp.: VA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30739 | Film No.: 221321268
SIC: 2834 Pharmaceutical Preparations